Zusammenfassung
Der MCAD-Mangel (OMIM #201450; Prävalenz etwa 1:11.500 Neugeborene) ist die häufigste Fettsäurenoxidationsstörung. Ihr liegt eine autosomal-rezessiv vererbte Aktivitätsminderung des Enzyms »mittelkettige Acyl-CoA-Dehydrogenase« zugrunde, sodass langkettige Fettsäuren, die im Fett der Nahrung und im Unterhautfett des Organismus enthalten sind, nur zu einem geringen Teil abgebaut werden können. Dementsprechend können sie weitgehend nicht zur Energiegewinnung des Muskels beitragen. Gleichzeitig ist die Produktion von Ketonkörpern, den neben Glukose wichtigsten Energielieferanten für das Gehirn, insbesondere während längerer Fastenperioden stark eingeschränkt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Literatur zu Abschn. 20.1
Wilcken B (2010) Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 33:501–506
Mayell SJ, Edwards L, Reynolds FE et al (2007) Late presentation of medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 30:104
Lang TF (2009) Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD). J Inherit Metab Dis 32:675–683
Schatz UA, Ensenauer R (2010) The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population. J Inherit Metab Dis 33:513–520
Santos L, Patterson A, Moreea SM et al (2007) Acute liver failure in pregnancy associated with maternal MCAD deficiency. J Inherit Metab Dis 30:103
Leydiker KB, Neidich JA, Lorey F et al (2011) Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening. Mol Genet Metab 103:92–95
Literatur zu Abschn. 20.2
Andresen BS, Olpin S, Poorthuis BJ et al (1999) Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 64:479–494
Bonnet D, Martin D, Pascale De L et al (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100:2248–2253
Spiekerkoetter U, Bennett MJ, Ben-Zeev B et al (2004) Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 29:66–72
Boer ME den, Wanders RJ, Morris AA et al (2002) Longchain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109:99–104
North KN, Hoppel CL, De Girolami U et al (1995) Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 127:414–420
Tyni T, Kivela T, Lappi M et al (1998) Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Ophthalmology 105:810–824
Olsen RK, Olpin SE, Andresen BS et al (2007) ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 130:2045–2054
Spiekerkoetter U, Haussmann U, Mueller M et al (2010) Tandem mass spectrometry screening for very longchain acyl-CoA dehydrogenase deficiency: The value of second-tier enzyme testing. J Pediatr 157:668–673
Vockley J, Rinaldo P, Bennett MJ et al (2000) Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab 71:10–18
Spiekerkoetter U, Lindner M, Santer R et al (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32:498–505
Van Hove JL, Grunewald S, Jaeken J et al (2003) D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 361:1433–1435
Bonnefont JP, Bastin J, Behin A et al (2009) Bezafibrate for an inborn mitochondrial beta-oxidation defect. N Eng J Med 360:838–840
Wilcken B, Leung KC, Hammond J et al (1993) Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 341:407–408
Wilcken B (2010) Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 33:501–506
Wilcken B, Wiley V, Sim KG et al (2001) Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr 138:581–584
Rinaldo P, Matern D, Bennett MJ (2002) Fatty acid oxidation disorders. Ann Rev Physiol 64:477-502
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wendel, U., Spiekerkötter, U. (2014). Fettsäurenoxidationsstörungen. In: vom Dahl, S., Lammert, F., Ullrich, K., Wendel, U. (eds) Angeborene Stoffwechselkrankheiten bei Erwachsenen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45188-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-45188-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45187-4
Online ISBN: 978-3-642-45188-1
eBook Packages: Medicine (German Language)